Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

PHASE3TerminatedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

May 24, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

February 26, 2021

Conditions
COVID-19
Interventions
DRUG

Placebo

Placebo administered BID approximately 12 hours apart

DRUG

Ruxolitinib

Ruxolitinb administered BID approximately 12 hours apart

Trial Locations (36)

14642

University of Rochester Medical Center, Rochester

15090

Allegheny Health Network, Wexford

15224

West Penn Hospital, Pittsburgh

19107

Jefferson University Hospitals, Philadelphia

19140

Temple University, Philadelphia

20007

Georgetown University Hospital, Washington D.C.

21224

Johns Hopkins University, Baltimore

27710

Duke University Medical Center, Durham

27858

East Carolina University, Greenville

32610

University of Florida, Gainesville

33511

Teradan Clinical Trials, Brandon

33606

Tampa General Hospital, Tampa

33613

University of South Florida, Tampa

45219

University of Cincinnati, Cincinnati

45429

Kettering Cancer Care, Dayton

46202

Indiana University Simon Cancer Center, Indianapolis

46219

Indiana University Health Central Indiana Cancer Centers, Indianapolis

53233

Aurora Research Institute, Milwaukee

55101

Healthpartners Cancer Care Center - Regions Hospital, Saint Paul

60153

Loyola University Medical Center, Maywood

60678

Northshore University Health System, Chicago

65804

Mercy Research, Springfield

70006

East Jefferson General Hospital, Metairie

77030

University of Texas Health Science Center At Houston - McGovern Medical School, Houston

78229

University of Texas Health Science Cente, San Antonio

78705

St David'S Medical Center, Austin

85258

Honor Health Research Institute, Scottsdale

92123

Sharp Memorial Hospital, San Diego

98801

Wenatchee Valley Hospital and Clinics, Wenatchee

198205

Sbih City Hospital 15, Saint Petersburg

02118

Boston Medical Center, Boston

01805

Lahey Hospital & Medical Center, Burlington

01655

University of Massachusetts Medical School, Worcester

07601

Hackensack University Medical Center, Hackensack

07103

Rutgers Njms Clinical Research Unit, Newark

07666

Holy Name Medical Center, Teaneck

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY